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Both theoretical predictions and experimental findings suggest that T cell populations can compete with each other.
There is some debate on whether T cells compete for aspecific stimuli, such as access to the surface on antigen-
presenting cells (APCs) or for specific stimuli, such as their cognate epitope ligand. We have developed an individual-
based computer simulation model to study T cell competition. Our model shows that the expression level of foreign
epitopes per APC determines whether T cell competition is mainly for specific or aspecific stimuli. Under low epitope
expression, competition is mainly for the specific epitope stimuli, and, hence, different epitope-specific T cell
populations coexist readily. However, if epitope expression levels are high, aspecific competition becomes more
important. Such between-specificity competition can lead to competitive exclusion between different epitope-specific T
cell populations. Our model allows us to delineate the circumstances that facilitate coexistence of T cells of different
epitope specificity. Understanding mechanisms of T cell coexistence has important practical implications for immune
therapies that require a broad immune response.
Citation: Scherer A, Salathe´ M, Bonhoeffer S (2006) High epitope expression levels increase competition between T cells. PLoS Comput Biol 2(8): e109. DOI: 10.1371/journal.
pcbi.0020109
Introduction
From an ecologist’s perspective, the maintenance of a broad
immune response, simultaneously recognising multiple anti-
genic regions of a pathogen, is puzzling. Ecological theory
predicts that the number of coexisting species in a certain place
and time cannot exceed the number of limiting resources in the
system [1]. To avoid competition, species are thought to
differentiate into their niche, which is their speciﬁc set of
resources they depend on to survive and reproduce. The lower
the resource differentiation between species, the smaller is
their niche overlap, and the weaker are the competitive
interactions between them. As in ecosystems, cells of the
immune system depend on limiting resources. T cells, one of
the main types of immune cells of the adaptive immune system,
proliferate in response to antigen stimuli, and they might
therefore compete for these stimuli. Yet, upon infection of a
host, T cell populations speciﬁc for many parts of the pathogen
tend to be triggered. What resource differentiation mecha-
nisms might allow the immune response against a pathogen to
be diverse? In this paper we use a stochastic computer
simulation model to investigate this question.
When a pathogen infects a vertebrate host, it is displayed to
the immune system on antigen-presenting cells (APCs) as
epitopes (eight-to-ten-amino-acid-long protein fragments),
bound to major histocompatibility complex (MHC) class I
molecules. T cells speciﬁc for any of the displayed epitopes
can become activated, upon which they proliferate rapidly
and clear pathogen-infected cells. Most effector T cells die
rapidly after the expansion phase of the response, unless they
reencounter remaining foreign antigen in the lymphoid
tissue. T cell populations speciﬁc for different epitopes of a
pathogen depend on a shared pathogen resource for their
expansion, and might therefore compete for this resource.
Nevertheless, coexistence of broad T cell responses, targeting
several or many epitopes of the pathogen, seems to be the
rule rather than the exception, both in acute infections [2–4]
and in chronic infections [5–8]. The functional importance of
broad immune responses is thought to be related to immune
escape, that is, the acquisition of mutations in the pathogen
that abrogate immune recognition. Therefore, broad re-
sponses are thought to improve control of infections. The
mechanisms that inﬂuence the breadth and immunodomi-
nance (i.e., size hierarchy of the different epitope-speciﬁc T
cell populations) of a T cell response are manifold, and
include differences in the T cell precursor frequency for a
certain epitope [9], epitope expression levels [10–12], and
competition between T cells [13]. This paper focuses on the
last factor and asks under which conditions T cells of
different epitope speciﬁcity compete with each other.
There is a considerable body of experimental data on T cell
competition, recently reviewed by Lanziavecchia, et al. [14],
that forms the basis of our current understanding of its
mechanistic basis. We here restrict ourselves to describing
examples of competition data for cytotoxic T cells (CD8þ T
cells), since these are the focus of our model. However, data
for competition between helper T cells (CD4þ T cells) also
exists (e.g., [15]). T cell competition ﬁrstly only occurs if the
resource, that is, the epitope displaying APCs, is limiting.
Hence T cell competition can only be observed when the
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ratio of T cells to antigen is high [16,17]. Second, competition
between T cells of different epitope speciﬁcity is related to
competition for access to the surface of APCs, since
presenting epitopes on separate APCs abrogates competition
[18]. The current understanding of T cell competition is
largely based on adoptive transfer experiments and on
epitope knock-out studies. In adoptive transfer experiments,
T cells speciﬁc for a particular epitope are transferred into a
mouse, and subsequently, the mouse is immunised with the
appropriate epitopes. A consistent result of adoptive transfer
experiments is that the transferred T cells interfere with the
host T cell response of the same epitope speciﬁcity (within-
speciﬁcity competition). However, the evidence regarding
competition between T cells of different epitope speciﬁcity
(between-speciﬁcity competition) is controversial. In Kedl, et
al. [18], the expansion of host T cells against epitopes
unrelated to that of the transferred T cell speciﬁcity was
reduced by the adoptive transfer, while in Probst, et al. [19] it
was not. This between-speciﬁcity competition was inter-
preted as competition for access to APCs. An analysis of in
vitro competition data with a mathematical model also
yielded evidence for competition for access to APCs [20]. In
epitope knock-out studies, one or several dominant epitope-
speciﬁc responses are reduced or inhibited fully, either by
interfering with presentation of the viral epitopes [21,22] or
by inducing thymic tolerance against them [23]. This
inhibition of dominant responses led to an increase of the
size of subdominant ones. Such compensation effects were
typically seen in secondary challenges, when the ratio of T
cells to antigen is high. However, in an epitope knock-out
experiment with a bacterial pathogen, the response to
subdominant epitopes was unaltered by the removal of one
or even two dominant epitopes from the bacterial pathogen
[24]. The reason for this discrepancy between compensation
effects in viral and bacterial infections is not clear.
Most previousmodelling approaches on T cell dynamics and
T cell competition describe the interactions between T cells
and infectious agents in a predator–prey-like manner [25,26],
where T cells corresponded to the predators and the epitope-
presenting APCs corresponded to the prey. APCs are often
modelled as independent T cell interaction sites on APCs that
are either free or engaged in an interaction with a T cell [25–
27]. Independent in this context means that the interaction of a
T cell with one APC site does not affect the status of other sites
on the same APC. These sites are further assumed to present
sufﬁcient amounts of epitope for each of the competing T cell
populations, and competition for access to these APC sites
leads to competitive exclusion of the subdominant T cell
speciﬁcity. Several modelling approaches have been made to
allow for coexistence of multiple epitope-speciﬁc T cell
populations, but in few is coexistence based on mechanistic
assumptions. One study modelled the expansion dynamics of
T cells heuristically, by feeding observed expansion and
contraction dynamics into the model [28]. Another assumed
a heuristic term of competition between T cells of the same
epitope speciﬁcity [29]. This increased within-speciﬁcity
competition implies a reduced niche overlap between T cells
of different epitope speciﬁcity and hence allowed for multiple
epitope-speciﬁc T cell responses to coexist. The assumed basis
for the higher intensity of within-speciﬁcity competition than
of between-speciﬁcity competition suggested by Korthals-
Altes, et al. [29] was that epitope-speciﬁc T cell populations
might expand locally in tissue, and hence interact more with
each other than with cells of other speciﬁcities. Finally, we
have recently developed a model in which the interaction
between T cells and APC sites leads to down-modulation of the
speciﬁc epitope. This assumption was based on experimental
evidence [30], and led to resource differentiation on APC sites,
thus allowing for coexistence of multiple epitope-speciﬁc T
cell populations [31]. A lot of the previous modelling work on
T cell competition has been done in the form of ordinary
differential equations. The beneﬁt of using ordinary differ-
ential equation models lies in their simplicity, which allows
some results to be derived analytically. However, ordinary
differential equations are also less ﬂexible in terms of
incorporating biological features of the modelled organisms.
In this paper, we develop an individual-based model (IBM) to
study potential mechanisms for coexistence of multiple
epitope-speciﬁc T cell populations. In particular, using an
IBM allows us to model APCs with multiple, interconnected T
cell interaction sites. This is in contrast to previous modelling
in which APC sites were considered as independent entities.
Our main ﬁnding is that, at low per APC epitope
expression levels, T cell competition is speciﬁc, namely for
access to the speciﬁc epitope ligand. Therefore, T cells of
different epitope speciﬁcity do not interfere with each others’
expansion, and diverse T cell responses can coexist. However,
at high epitope expression levels, competition becomes
aspeciﬁc, namely for access to the surface of the APC,
resulting in competitive exclusion. Our results suggest that
the epitope expression level per APC might critically affect T
cell competition and coexistence. This effect can only be
observed when T cell interaction sites on APCs are
interconnected, as is the case in our IBM.
Results
Our simulation describes the dynamics of virally infected
cells, APCs, and cytotoxic T cell populations speciﬁc for
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Synopsis
Pathogens are masters of disguise, and frequently escape recog-
nition by the immune response. Therefore, broad immune
responses, directed at many epitopes of the pathogen, are thought
to improve control of infection. There is evidence that competition
between immune cells of different epitope specificity reduces the
breadth of the immune response. It has been suggested that the
resource that T cells compete for is access to antigen-presenting
cells (APCs). However, the experimental data regarding competition
for access to APCs is controversial. In this study, Scherer, Salathe´,
and Bonhoeffer have used an individual-based model to investigate
the mechanisms of T cell competition. They find that T cells only
compete for access to APCs when epitopes are expressed
abundantly on APCs. In contrast, when epitope expression is
limiting, competition is for the specific epitope rather than for
access to APCs. The distinction between competition for epitope
and for access to APCs is relevant because the model predicts
qualitatively different outcomes for either case. When competition is
for the specific epitope, different epitope-specific T cell responses
coexist readily and hence the immune response is broad. However,
when T cells compete for access to APCs, immunodominant T cell
responses can outcompete subdominant ones, which leads to
narrow immune responses.
Epitope Expression and T Cell Competition
different epitopes of the virus. In Figure 1 the central features
of the model are illustrated, and in the Materials and Methods
section the model is described in detail and the parameter
values are listed.
Less Is More: T Cell Coexistence Depends on Epitope
Expression Levels
In Figure 2, we show simulations of the dynamics of two T
cell populations speciﬁc for two epitopes of a virus in acute
(Figure 2A and 2B) and chronic (Figure 2C and 2D) infection,
for either high (Figure 2A and 2C) or low (Figure 2B and 2D)
per-APC expression levels of the epitopes. When epitope
expression levels are high, the subdominant T cell population
expands very poorly, and is eventually outcompeted by the
immunodominant one, in both acute and chronic infection.
In contrast, at low epitope expression levels, both responses
expand well and coexist. Why do T cells of different epitope
speciﬁcity interfere more with each other when epitopes are
expressed at higher densities on APCs?
To address this question, we follow T cell coexistence,
deﬁned as the ratio of the subdominant versus the immuno-
dominant immune response size after 400 days of chronic
infection, as a function of the per-APC epitope expression.
Figure 3 reveals three qualitatively different regimes of T cell
competition: (i) only speciﬁc competition, (ii) both speciﬁc
and aspeciﬁc competition, and (iii) only aspeciﬁc competi-
tion. In the following, we discuss in more detail how epitope
expression levels shape each of these competition regimes.
T cell coexistence is maximal ðregion ðiÞÞ when:
perAPC Expression Level of Each Epitope
 Number of Sites perAPC
Number of Epitopes Types
3Amount of Epitope
per APC Needed for T Cell Activation ð1Þ
For the parameter settings used so far, where a T cell
requires 50 copies of epitopes to be activated and APCs have
six T cell binding sites, Equation 1 shows that competition is
for the speciﬁc epitope for epitope expression levels up to
150 copies of each epitope per APC. The diagram at the left
of Figure 3 illustrates why T cells of different epitope
speciﬁcity do not compete for each other at such low epitope
expression levels. When a T cell forms a conjugate with an
APC, the amount of speciﬁc epitope that the T cell requires
for activation is allocated to that site and is thus inaccessible
for other cells. If for example three T cells speciﬁc for the
immunodominant epitope have formed conjugates with an
APC that expresses 150 copies of each epitope, the remaining
three sites will solely present the subdominant epitope.
Hence, under such limiting epitope expression levels, T cells
of different epitope speciﬁcity do not compete with each
other directly, and the level of T cell coexistence (i.e., the
ratio of subdominant to immunodominant population size) is
given by their relative T cell afﬁnities.
Competitive exclusion ðregion ðiiiÞÞ occurs when:
perAPC Expression Level of Each Epitope  Number of
Sites per APC3Amount of Epitope per
APC Needed for T Cell Activation ð2Þ
For epitope expression levels above 300 copies of each
speciﬁcity (region (iii)), all T cell binding sites of the APCs
present sufﬁcient copies of each epitope speciﬁcity to allow T
cells to form a conjugate. At such high epitope expression
levels, the limiting factor is no longer epitope, but rather
access to T cell binding sites on APCs. In this situation, both T
cell speciﬁcities depend on the same resource, i.e., competi-
tion within and between T cell speciﬁcities is equivalent, and
the immunodominant T cell speciﬁcity outcompetes the
subdominant one because it replicates faster (higher proba-
bility of proliferation). Therefore, T cell coexistence is lost at
high epitope expression levels.
Figure 1. The Basic Features of the IBM
The production of APCs depends on the number of virally infected cells.
APCs express two to n different pathogen epitopes. We refer to the
infecting pathogen as a virus in this paper, but the model applies to all
intracellular pathogens and extracellular pathogens that enter the MHC
class I presentation pathway via cross-presentation [78,79]. For simplicity,
APCs present the same amount of each epitope, though in the
discussion of this paper, we discuss the effect of skewed epitope
expression levels. Epitopes are assumed to be able to move freely in the
membrane of the APC, and when a T cell forms a conjugate with a site
on an APC, the amount of epitope the T cell requires for activation is
allocated into the site of T cell:APC interaction. Unless stated otherwise,
each APC is assumed to have six T cell binding sites. In the illustration,
each blue and red crown-like symbol on the surface of an APC represents
ten copies of epitope for which blue- and red-coloured T cells,
respectively, are specific. T cells are assumed to require 50 copies of
their cognate epitope to become activated. Upon dissociation of the
conjugate, T cells become activated with a probability set by the
probability of proliferation of the T cell (‘‘T cell affinity’’). Upon activation,
T cells go through n rounds of programmed proliferation (n is set to five
unless stated otherwise), after which they become effector T cells and
clear virally infected cells. We assume that T cells spend some time in
infected tissue before reentering the blood circulation and homing back
to lymphoid tissue. Hence, scanning of APCs by T cells recommences
after an average of five days after proliferation. Until they form a new
conjugate with an APC, they perform their effector function and kill
virally infected cells. T cells and APCs die with a probability of 0.2 per day.
A more detailed description of the model and of the parameter values
used in the model can be found under Materials and Methods.
DOI: 10.1371/journal.pcbi.0020109.g001
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Figure 2. T cell Dynamics in Acute and Chronic Infection
In these simulations, two epitopes of a pathogen are displayed at equal densities on APCs. The number of epitope copies required for T cell activation is
set to 50 copies, and APCs have six T cell binding sites.
(A and C) Both epitopes are displayed at high expression levels of 300 copies each (per APC).
(B and D) Both epitopes are displayed at low expression levels of 150 copies each. Acute infection is modelled by assuming a higher proliferative
capacity of T cells in acute than in chronic infection, namely seven versus five rounds of proliferation, respectively. T cell affinities are set to 0.07 and 0.1
for the subdominant and immunodominant T cell specificity, respectively. All other parameter settings are listed in Table 1.
DOI: 10.1371/journal.pcbi.0020109.g002
Figure 3. The Effect of the per-APC Epitope Expression Level on T Cell Coexistence
Shown is the mean 6 standard deviation of three replicate simulations. The black dashed line indicates the ratio of epitope affinities of the
subdominant and the immunodominant T cell specificity, which were set to 0.07 and 0.1, respectively. All other parameter settings are listed in Table 1.
Left and right of the plot are illustrations of an APC with low (150 copies) and high (300 copies) per-APC epitope expression levels, respectively. In the
illustrations, three T cells of the immunodominant specificity are conjugated with the APC. For low epitope expression levels this leads to a situation in
which the remaining space on the APC only presents the subdominant epitope, while for high epitope expression levels the remaining space presents
both epitope specificities.
DOI: 10.1371/journal.pcbi.0020109.g003
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For epitope expression levels ranging from 150 to 300
copies of each speciﬁcity (region (ii)), some APC sites only
express enough of one epitope speciﬁcity, while others
express enough of both speciﬁcities. This means that there
is both shared and unshared resource for the two T cell
populations. The more APC sites express sufﬁcient epitope of
both speciﬁcities, the higher the competition between T cells
of different epitope speciﬁcity, and consequently, the lower
the coexistence of the two T cell speciﬁcities.
In Figure 3, the relative afﬁnity of the subdominant versus
the immunodominant T cell speciﬁcity was 0.7. We next
investigated whether the range of afﬁnities of T cells that can
coexist is limited to very similar afﬁnities, or if T cells of quite
distinct afﬁnities can coexist. In Figure 4, T cell coexistence is
plotted over a wide range of relative afﬁnities of the
subdominant versus the immunodominant speciﬁcity. The
black line in Figure 4 represents simulations with high
epitope expression levels (300 copies of each epitope), the red
line represents medium epitope expression levels (200 copies
of each epitope), and the blue line represents low epitope
expression levels (150 copies of each epitope). Since resource
differentiation is complete at this low epitope expression
level of 150 copies of each epitope, the ratio of the two T cell
populations (the T cell coexistence in Figure 4) equals the
relative afﬁnity of the subdominant versus the immunodo-
minant T cell. Therefore, the slope of T cell coexistence
versus relative T cell afﬁnity at low epitope expression levels
equals one. At very low afﬁnity of the subdominant T cell
speciﬁcity, coexistence is lost, both at low and medium
epitope expression level. This is because, at low epitope
afﬁnity, the subdominant T cell population divides too rarely
to compensate for the death rate of the T cells.
The Surface Area of APCs Sets the Maximal Breadth of an
Immune Response
Up to this point we have studied the question of
competition and coexistence of multiple epitope-speciﬁc T
cell responses in the simplest setting of two epitopes and two
T cell populations. In this section, we investigate T cell
coexistence in a model with many epitopes, and ask whether
there is a limit to the number of T cell populations that can
coexist in equilibrium. To address this question, we simulate
our model with APCs that have six or ten T cell binding sites
(Figure 5A and 5B versus Figure 5C and 5D, respectively).
When epitopes are expressed at exactly the amount required
to activate a T cell (i.e., 50 copies), essentially all presented
epitopes are targeted by a T cell response. If epitope
expression levels are increased above the minimal amount
needed for T cell activation (i.e., for epitope expression levels
of 100 copies and higher), epitope-speciﬁc responses are lost
sequentially, in order of their afﬁnity ranking. Interestingly,
for this range of epitope expression levels, the diversity
proﬁles of T cell responses generated with six-site APCs
presenting six or ten epitopes are indistinguishable. Similar
results were obtained with APCs with ten T cell binding sites.
For these, the proﬁles of T cell response diversity of APCs
presenting 10 and 17 epitopes were equivalent for all but the
epitope expression level of 50 copies per epitope per APC.
Again, at this level, essentially all presented epitopes were
targeted (Figure 5C and 5D).
These data suggest that when the total number of epitope
types presented on an APC is larger than the available space
in terms of T cell binding sites some epitopes will not elicit an
immune response, even if epitopes are expressed at very low
levels. In the special case when epitope presentation equals
the amount a T cell requires for activation, the number of
coexisting T cell speciﬁcities can exceed the number of T cell
binding sites on the APC. For example, on an APC with ten T
cell binding sites that presents 17 epitope types at 50 copies
each, 15 epitopes were targeted by the immune response. This
is because as soon as a T cell of a certain speciﬁcity has
formed a conjugate with the APC, all other sites cannot
stimulate T cells of the same speciﬁcity anymore. Hence, the
within-speciﬁcity competition is much stronger than the
between-speciﬁcity competition.
Epitope Expression Levels in Infections
Broad immune responses are thought to be important to
protect infected hosts against rapidly evolving pathogens that
can accumulate mutations that interfere with presentation of
the epitope or recognition of the epitope by the speciﬁc T
cells. Loss of an immune response due to such mutations is
called immune escape, and is thought to be a central problem
of the immune system’s ﬁght against HIV [32–37].
Our model suggests that the breadth of T cell immune
responses is maximal when the per APC epitope expression
levels are close to what a T cell requires for activation. Data
on epitope expression levels revealed copy numbers between
one and 10,000 per cell, although most lie between ten and
1,000 [12,38–49]. The epitope expression levels are likely to
differ between different pathogens, depending on the
genome size of the pathogen and on the absolute amount
of pathogen protein that is produced in infected cells.
The relationship between T cell coexistence and the per-
APC expression level of each epitope depends on the
assumed size of the APC, on the number of different
pathogen epitopes that are displayed on the surface of the
Figure 4. T cell Coexistence Depends on the Relative Affinity of the
Immunodominant versus the Subdominant T Cell
In the simulations for this plot, the affinity of the immunodominant T cell
specificity is set to 0.1, and the affinity of the subdominant is increased
from zero to 0.1. The black, red, and blue lines are for high, medium, and
low epitope expression levels of 300, 200, and 150 copies of each
epitope, respectively. Shown is the mean 6 standard deviation of six
replicate simulations. All other parameter settings are listed in Table 1.
DOI: 10.1371/journal.pcbi.0020109.g004
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APC, and on the sensitivity of T cells to epitope, i.e., the
number of cognate ligands a T cell needs to interact with to
become activated (Equations 1 and 2 and Figure 6A). Figure 6
shows how the relationship of T cell coexistence on the per-
APC epitope expression level changes for increasing size of
APCs (Figure 6B), increasing T cell sensitivity (Figure 6C), and
increasing number of displayed epitope types (Figure 6D). In
our simulations, APCs were assumed to be of a size such that
six or ten T cells could interact simultaneously with each
APC. However, especially dendritic cells (DCs), an important
type of APCs, have a large surface area, which might allow for
as many as 300 T cells to simultaneously interact with them
[50]. Figure 6B shows that increasing the surface of an APC
increases the region of epitope expression levels at which T
cell coexistence is maximal. This is because competition for
access to APCs is less severe when the surface area of an APC
is larger. What happens if T cells are more sensitive to
epitope, and require less than the 50 copies we assumed so
far? Experimental studies observed that as few as one to ten
copies of epitope might be sufﬁcient to generate calcium
ﬂuxes (one of the earliest responses of T cells to antigen
stimuli) in T cells [41,51–53]. When T cells are more sensitive
to their cognate ligand, the T cell coexistence curve shifts to
the left (Figure 6C). This is because epitope is less limiting
when T cells require less epitope to become activated. As
soon as epitope ceases to be limiting, access to the APC
becomes limiting. Finally, when more different pathogen
epitopes are displayed on the surface of the APC, this reduces
the epitope expression level up to which T cell coexistence is
maximal, but does not affect the epitope expression level at
which the immunodominant T cell response outcompetes all
other responses (Figure 6D). Competitive exclusion occurs
when all sites on an APC are suitable for all T cell speciﬁcities
(or at least for the dominant speciﬁcity), and is independent
Figure 5. T Cell Diversity Decreases with Increasing per-APC Epitope Expression Level
APCs with six T cell binding sites were simulated with six or ten presented epitopes (A and B, respectively), and APCs with ten T cell binding sites with
10 and 17 epitopes (C and D, respectively). Per bar, the different epitope-specific T cell populations are stacked and represented in different colours. For
increasing epitope expression levels, T cell diversity drops from its maximum, which is when epitopes are presented at the amount necessary to activate
a T cell (i.e., 50 copies of epitope), down to one for high epitope expression levels. Diversity reaches one when each epitope is expressed at sufficient
levels to activate a T cell of the corresponding epitope specificity at each site of the APC, which is at epitope expression levels of 300 and 500 for APCs
with six and ten T cell binding sites, respectively. T cell affinities of epitopes presented on APCs with six sites were as follows: for six epitopes, [0.05, 0.06,
0.07, 0.08, 0.09, 0.1], and for ten epitopes [0.03, 0.035, 0.04, 0.045, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1]. On APCs with 10 sites and 10 epitopes, affinities ranged
from 0.0375 to 0.06, and on APCs with 10 sites and 17 epitopes, affinities ranged from 0.02 to 0.06. Subsequently ranked T cell specificities always
differed by 0.0025 in terms of their affinities. All other parameter settings are listed in Table 1.
DOI: 10.1371/journal.pcbi.0020109.g005
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of the number of epitope types. However, maximal coex-
istence depends on each APC site only displaying one epitope
type. Hence, the closer the number of epitope types to the
number of T cell binding sites per APC, the sooner
competition for access to APC sites sets in. Summarising,
for APCs with a large cell surface, the range of epitope
expression levels for which competition between T cells is for
the speciﬁc epitope is quite wide. If T cells are very sensitive
to their cognate ligand, this reduces the range of epitope
expression levels for which T cells do not compete with each
other.
Discussion
In this study, we investigated T cell competition and
coexistence with an individual-based stochastic simulation
model in which APCs have multiple T cell interaction sites,
and addressed the following two questions: 1) Under what
conditions do T cells speciﬁc for different epitopes of a
pathogen compete with each other, and 2) why do some
immunogenic epitopes fail to elicit a measurable T cell
response? For the ﬁrst question, the model predicts that,
when epitope expression levels are low, competition is for the
speciﬁc epitope, and hence immunodominant and subdomi-
nant T cells of different epitope speciﬁcity coexist readily.
However, at high epitope expression levels, T cells compete
for access to the APC, which is a shared resource. This
competition can severely reduce the expansion of the
subdominant T cell speciﬁcity, or even lead to the extinction
of the subdominant T cell speciﬁcity (i.e., competitive
exclusion). The second question, why only so few of all
presented pathogen epitopes are targeted upon infection, has
also been debated elsewhere [54,55]. The theoretical max-
imum breadth of T cell immune responses in our model is set
by the maximum number of T cells that can simultaneously
interact with one APC. Thus the size of an APC and the level
at which epitopes are expressed, might explain why only a
subset of the presented epitopes elicit measurable T cell
immune responses.
The results shown in this paper are based on simulations in
which epitope expression levels of the two epitopes are equal
in amount and constant during the lifetime of the APC.
Differential expression of epitopes [13,55], and the kinetics of
epitope expression, can affect immunodominance [23].
Skewed epitope expression in favour of the low afﬁnity T
cell speciﬁcity by higher expression of the epitope can
compensate partially or fully for the afﬁnity disadvantage of
the subdominant T cell response. On the other hand, a
subdominant T cell speciﬁcity will be outcompeted more
rapidly if the epitope of the immunodominant T cell
speciﬁcity is overexpressed (unpublished data). Similarly, if
the subdominant epitope is expressed earlier than the
immunodominant one during the lifespan of an APC, this is
expected to facilitate coexistence. Antia, et al. have argued
that the lack of competition between T cell populations
speciﬁc for different epitopes of a pathogen, such as observed
in Vijh, et al. [24], may be due to the partly antigen-
independent nature of T cell expansion [56]. In acute
infection, when naive T cells are activated by their cognate
epitope, antigen is usually abundant and hence T cells of
different epitope speciﬁcity can expand independently of
each other. Indeed, our model simulations show that
increasing the rounds of programmed proliferation upon
activation accelerates clearance of the pathogen in acute
infection and leads to a slightly improved relative expansion
of the subdominant versus the immunodominant T cell
Figure 6. The Effect of Varying APC Size, T Cell Sensitivity, and the Diversity of Displayed Epitopes on T Cell Coexistence
The per APC epitope expression level of each epitope up to which T cell coexistence is maximal depends on the size of APCs, the number of different
epitope types that are presented, and the amount of epitope a T cell needs to become activated. The epitope expression level above which the
immunodominant T cell population outcompetes all others solely depends on the APC size and on the amount of epitope required for T cell activation
(A). In the three graphs below, the effect of changing any one of these parameters is shown.
(B) The larger the surface area of APCs, the wider the range of per APC epitope expression levels for which coexistence of T cells is maximal.
(C) The more sensitive T cells are to epitope (i.e., the lower the amount of epitope a T cell requires to become activated), the more narrow the range of
epitope expression levels with maximal coexistence of T cell populations of different epitope specificity.
(D) The number of different pathogen epitopes that are presented on an APC effects the per APC epitope expression level up to which T cell
coexistence is maximal, but not the level at which the immunodominant T cell specificity outcompetes the other epitope-specific T cell populations.
The higher the number of different epitope types, the more narrow the range of per APC epitope expression levels at which T cell coexistence is
maximal.
DOI: 10.1371/journal.pcbi.0020109.g006
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population than that shown in Figure 2A (unpublished data).
However, the equilibrium T cell coexistence in chronic
infection is robust to changes in the proliferative capacity
of T cells (unpublished data). One other simplifying assump-
tion in our model was that all APCs express the same amount
of epitope. We checked for the effect of variability in epitope
expression levels between APCs in our simulations and found
that variability in epitope expression levels between APCs
yields a moderate increase in the range of epitope expression
levels at which T cells can coexist.
Our theoretical predictions offer potential explanations
for some of the controversial results observed in T cell
competition experiments. However, it remains problematic
to compare different experimental systems directly. Firstly,
the per-APC epitope expression levels are often not known.
Secondly, the relationship between T cell coexistence and
epitope expression levels is sensitive to factors such as the size
of APCs, the sensitivity of the epitope speciﬁc T cells, and the
number of different pathogen epitopes that are presented
(see Figure 6). One example of controversial results are two
adoptive transfer studies. In one, using OVA peptide speciﬁc
OT-1 T cells, Kedl, et al. observed competitive interactions
between T cells of different epitope speciﬁcity [18], whereas
in another, using LCMV infection, Probst, et al. did not ﬁnd
evidence for competition [19]. Our theory would predict that
epitope expression levels were low in the Probst study, and
that therefore no competition was observed, whereas they
were high in the Kedl study, leading to competitive
interactions between the two T cell populations. However,
part of the Kedl study was performed with DCs loaded with
very low concentrations of peptide (approximately 109 M).
So epitope expression levels alone cannot explain the
discrepancy. Importantly, however, the OVA-speciﬁc T cells,
used in the Kedl study, are known to be very sensitive to the
OVA-peptide. Our model predicts that for highly sensitive T
cells, competition between T cells of different epitope
speciﬁcity already occurs at lower epitope expression levels,
because access to APCs rather than epitope becomes limiting
at lower epitope expression levels (see Figure 6C). Hence, it is
conceivable that the high sensitivity of OVA-speciﬁc T cells
leads to competition for access to APCs in the Kedl study,
although the epitope expression levels in the Kedl and the
Probst studies may have been similar.
The current view on T cell competition is that T cells of
different epitope speciﬁcity can compete with each other
when the ratio of T cells versus antigen is high and when
epitopes are presented on shared APCs [14]. Our results
suggest that, even when these prerequisites are met, T cells of
different epitope speciﬁcity will only compete with each
other when epitope is not limiting, i.e., when the per-APC
epitope expression levels are high. Our model prediction
could be tested experimentally by immunising mice with
APCs loaded with high or low epitope expression levels. Our
model predicts that immunodominance will be more pro-
nounced at high than at low epitope expression levels.
Materials and Methods
The code for our individual-based simulation was written in JAVA
and is available upon request. Our IBM describes the dynamics of
virally infected cells, APCs that display epitopes of the virus, and
cytotoxic T cells that recognise these epitopes. Our model is based on
that of De Boer, et al. [25], with one major difference: in De Boer’s
model, APCs consist of a set of independent sites that T cells can
interact with to become activated. In our model, the sites on an APC
are connected and thus not independent. This means that con-
jugation of a T cell with an APC site can affect availability of epitopes
on adjacent sites.
Time-step size and duration of simulations. Each virally infected
cell, APC, and T cell in our model is initialised with a certain set of
speciﬁc properties. In each time step, a certain set of events (for
example, T cell activation or death) can take place. The length of a
time step is set to 1/50th of a day. This way, each event in the
simulation occurs with only a small likelihood per time step, and
hence the order in which methods are ‘‘called’’ in the simulation is
irrelevant. All simulations last 400 days (20,000 time steps). For most
parameter settings, the simulations equilibrate within that timespan.
The equilibria in our simulations are either stable steady states or
stable oscillations, or, in some cases, slow transients. In any case,
simulations are stopped after 400 days. All rates (time-dependent
parameters) were scaled by the time-step size at initialization of the
simulations, i.e., converted into per-time-step probabilities.
Dynamics of virally infected cells. We set the probability of
proliferation of T cells and the rate of clearance of infected cells by T
cells such that the virus is not eradicated by the T cell response, but
causes a chronic infection. Viral replication is assumed to be density
dependent, i.e., in the absence of a T cell response, the population of
virus-infected cells grows to its carrying capacity, which is set to 105.
For the sake of simplicity, we do not explicitly model free viral
particles and target cells, but only virally infected cells.
Virally infected cells are cleared by T cells at a probability given
by the product of the rate of clearance of infected cells, which is set
to 105, and the number of effector T cells (see the next section, APCs).
Although we refer to the pathogen as a viral pathogen throughout this
chapter, the model can be applied to any pathogen that is displayed on
MHC class I molecules on APCs, including intracellular bacteria or
cross-presented extracellular pathogens (see, e.g., reviews [57,58]). We
chose not to include the T-helper cell populations in our model,
because this would add an additional layer of complexity and because
T cell competition experiments that use epitope-loaded, mature DCs
as antigen are also conducted in the absence of T-helper cells.
APCs. The biology of epitope presentation on MHC class I
molecules in infected APCs is complex. In our model, we implement
antigen presentation heuristically. We assume that the number of
infected APCs is proportional to the number of virally infected cells,
and set the number of new epitope-presenting APCs per day to be the
product of the infected cells and a constant, r. The APCs in our
model have multiple T cell binding sites, and the default number of T
cell binding sites per APC is set to six. Recent imaging studies have
observed one to 14 T cells interacting simultaneously with one DC,
which is an important type of APC [59,60]. However, the total surface
area of DCs might be large enough to allow for up to 300 T cells to
interact with one DC simultaneously [50].
In our model, we assume that a T cell needs to interact with 50
copies of its speciﬁc epitope–MHC complex to form a conjugate with
an APC, and that each APC expresses 300 copies of each of the two
epitopes. Throughout this paper, the per-APC epitope expression
level is varied and indicated at each simulation result. Quantitative
data on epitope expression levels on APCs in the literature suggest
values ranging from one to 10,000 copies per epitope [12,45–49]. The
minimal number of epitope ligands needed to activate a T cell is very
low, and may be less than ten copies [53,61]. For our model studies,
only the ratio of the epitope expression level per APC and the
number of epitope copies required to activate a T cell is relevant.
This ratio needs to be larger than or equal to one to allow one or
more T cells of a particular speciﬁcity to interact and potentially
become activated by an APC. In our model, epitopes are assumed to
move freely on the surface of APCs, and, when a T cell forms a
conjugate with an APC site, the amount of epitope the T cell needs to
become activated is allocated to this site. For simplicity, the two
foreign epitopes modelled here are assumed to be presented in equal
densities on the APC. Effects of unequal presentation densities are
discussed under Discussion.
APC death. In vitro data on the survival of DCs suggests that they
live on average for two to six days [62,63]. In our model, we set the
average lifespan of APCs to ﬁve days (the per-day probability of death
of an APC is set to 0.2). When an APC dies, the T cells that are
conjugated to it dissociate without becoming activated. We have not
included the killing of APCs by T cells, since including APC killing by
T cells does not alter the results qualitatively (unpublished data).
T cells. Naı¨ve T cell precursor frequencies have been estimated to
be approximately one in 105 cells, that is, 10 to 100 precursor cells per
speciﬁcity per mouse [64–66]. At the start of a simulation, we seed
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small populations of two types of epitope-speciﬁc T cells (50 cells
each) into the model immune system. The two T cell speciﬁcities can
be distinguished by their T cell receptor speciﬁcity (set to 0 or 1), and
only differ from each other in terms of their probability of
proliferation upon dissociation from a conjugate with an APC site.
In our model, the probability of proliferation is a composite
parameter that describes the intensity of signals a T cell receives
while it is in conjugation with an APC site. This signal strength is
shaped, among other things, by the TCR density on the T cell
membrane, the afﬁnity of a TCR to its cognate epitope, and the
density of the cognate epitopes on the APC surface (the latter is set
equal for both epitopes). For simplicity, we will refer to T cells with a
high probability of proliferation as immunodominant or high-afﬁnity
T cells and to those with a low probability of proliferation as
subdominant or low-afﬁnity T cells. T cells occur in the following
states: as effector T cells, conjugated with an APC site, or
proliferating.
‘‘Scanning’’ and conjugate formation. In the model, there are two
kinds of effector T cells: ‘‘scanning’’ effectors and ‘‘pure’’ effectors. A
scanning effector T cell scans 50 randomly picked APCs with free
binding sites for antigenic stimuli per day and, upon success, it
engages in a conjugate with the binding site. We assume that T cells
only scan APCs with one or more free binding sites. This is because
APCs that are fully covered with T cells are no longer accessible to T
cells. Most data on T cell and DC interaction rates count the number
of T cells that scan one DC per hour when antigen is absent. These
estimates range from 500-5000 per hour [50,59,60,67,68]. For a T cell
precursor frequency of one in 105 cells, this would mean that a DC
encounters a T cell speciﬁc for a particular epitope once every 20–
200 hours (i.e., approximately one to ten per day). For the situation
when a speciﬁc antigen is present, and speciﬁc T cell levels are far
higher than precursor levels, the contact rate is naturally much
higher, motivating us to set the number of APCs that a T cell scans
per day to 50. In equilibrium, APCs with free binding sites are very
rare. If all APCs are full, scanning of APCs by T cells stops until some
sites become free again. Once a T cell has conjugated with a site on an
APC, it remains bound to the APC site for an average of one day.
Upon dissociation from the conjugate, the T cell proliferates
according to its probability of proliferation (also referred to as ‘‘T
cell afﬁnity’’).
Experimental data on the dynamics of the interactions between
APCs and T cells suggests that T cells ﬁrst engage in multiple, short
encounters, then in longer interactions that last up to 30 minutes
[69]. For our model results, both kinds of interactions are
qualitatively equal. What matters is the total interaction time, during
which a T cell occupies space and/or epitopes on an APC. Hence, we
have condensed the multiple conjugate interactions into one long-
lasting interaction of an average of one day.
Proliferation. T cells become activated by interacting with an
APC site that presents its speciﬁc epitope. The probability that a T
cell starts to proliferate upon dissociation of the T cell–APC
conjugate is varied in the simulations, but usually set to values
around 0.1. Recently, it was shown that T cells, after an initial lag-
phase of approximately one day, go through ﬁve to ten rounds of
proliferation without the need for reexposure to the antigen [70–
73]. Previously, it was assumed that T cells require antigen contact
for each round of expansion. This antigen-independent sequence of
several rounds of division upon activation is referred to as
programmed proliferation [74]. In our model, activation of the T
cell upon dissociation from the APC immediately leads to the ﬁrst
of n rounds of programmed proliferation. The subsequent rounds of
proliferation are more rapid, and occur with a rate of three per day.
In our model, the default number of rounds of programmed
proliferation of an activated T cell is set to ﬁve. In our model, we do
not consider clonal exhaustion [75]. Hence, if antigen is not cleared,
epitope-speciﬁc T cell populations can theoretically live indeﬁnitely.
Still, because of their high death rate, individual T cells typically
only become activated and go through programmed proliferation
once or twice during their lifespan (see section on T cell mortality
further on).
Effector function. After n rounds, proliferation stops and the T
cells become ‘‘pure’’ effector cells. Effector T cells clear virally
infected cells, and do not scan APCs for further antigenic stimulation.
T cells remain in the pure effector state for an average of ﬁve days
and subsequently start scanning APCs again, in search of antigenic
stimuli. Scanning T cells continue to clear virally infected cells until
they engage a new conjugate with an epitope-presenting T cell
binding site on an APC. For simplicity, we assume that there is no
maximum to the number of times that T cells can become activated
and can undergo programmed proliferation.
T cell mortality. Model-assisted data analysis has estimated
mortality rates for T cells between 0.05 and 0.2 per day [76,77]. In
our model, we set the rate of death of T cells to 0.2 per day. We
further assume that T cells do not die during programmed
proliferation.
Parameter values. The parameter values used in our model
simulations are, where possible, based on experimental values (see
Table 1). Since it is our objective to study under what circumstances T
cell populations of different epitope speciﬁcity are in competition
with each other, we look at longer-term interactions of T cell
populations and their resource, and hence evaluate equilibrium
results of chronic infections. When T cells are stimulated very
efﬁciently by the antigen, or if they have a very high viral killing rate,
they can rapidly clear infections. In our model, efﬁcient stimulation
of T cells can arise from, for example, high probabilities of
proliferation of T cells, a high number of rounds of proliferation
upon activation, or very efﬁcient antigen presentation by infected
APCs (i.e., high r).
Table 1. Parameter Values of the Model and Experimental Estimates
Cell Type Parameter Default in Model Experimental Value Reference
Virally infected cells Carrying capacity 105cells
Intrinsic growth rate 0.5 day1
Per T cell clearance rate of infected cells 105 day1
APCs Rate of production of new virus presenting APCs 0.004 day1
Number of T cell binding sites per APC 6 10–300 [50,59,60]
Epitope expression level 300 and varied 102104 [45]
APC death rate 0.2 day1 0.15–0.5 day1 [62,63]
Rate of dissociation of a T cell: APC conjugate 1 day1 1–24 day1 [60,69]
T cells T cell precursor frequency 50 10–100 [64–66]
Number of APCs scanned by a T cell 50 day1
Minimal number of epitopes required to bind to an APC site 50 copies 2–10 [53,61]
Probability of T cell proliferation upon dissociation of the APC:T cell
conjugate (‘‘T cell affinity’’)
’0.1 0.1–0.25 day1 [68]
Duration of one round of T cell division 8 hours 0.5–2 days [70–72]
Number of cycles of programmed proliferation 5 3–10 [70–72]
Rate with which T cells start scanning for antigen after proliferation 0.2 day1
T cell death rate 0.2 day1 0.05–0.2 day1 [76,77]
DOI: 10.1371/journal.pcbi.0020109.t001
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